Mary L. Chandler, MD, FACOG

PROFESSIONAL EXPERIENCE

2011 - 2013                       Cell Therapeutics. Seattle WA -- Associate Director of Medical Writing
Regulatory and peer-reviewed medical writing for oncology drug development

2003 - 2011 Axio Research LLC, Seattle, WA Medical Writer/ Project Director / Biostatistician
Regulatory and peer-reviewed medical writing, grant writing, statistical analysis, project management, and data monitoring committee management for clinical trials

2001 Pacific Northwest National Laboratories, Richland, WA
Division of Computational Science and Mathematics.  Development of computer graphical models of biochemical pathways

1991 - 2000 Private Practice, Obstetrics and Gynecology, Richland, WA  
Owner and manager of medical practice;  retired from practice in June 2000 to return to graduate school
   

DEGREES


Duke University School of Medicine 
University of Southern California                                             
California State University at Dominguez Hills       
MD, 1987
MS, Biostatistics 2003
BA. Biological Sciences 1982
Minor, Bio-organic Chemistry
                                                                      
OTHER EDUCATION


University of Colorado Health Sciences Center
Certified Professional Medical Writer (Certificate)
Washington State University at Tri-cities
University of California at Los Angeles
Internship and Residency, Obstetrics and Gynecology, 1987 1991
2010
Computer science courses 1998 - 2000
Mechanical engineering, physics, mathematics courses 1974 1977
     
  
PROFESSIONAL ACTIVITIES


Member, 401K Committee 2003-present.  Axio Research, LLC
Chairman, Medical Committee 1996-2000.  Planned Parenthood of Central Washington
Chairman, Dept. of Obstetrics and Gynecology 1996-1998.  Kadlec Medical Center, Richland, WA
Board Member 1998-2000.  Mid-Columbia Independent Medical Practitioners
Member of several hospital committees 1993-2000:  Medical Executive, Quality Control, Cancer, Infection Control and Laser Committees.  Kadlec Medical Center, Richland, WA


COMMUNITY ACTIVITIES


Treasurer / Board of Directors, Chopin Foundation of the U.S., Northwest Council 2005-present
Secretary / Board of Directors, American Association of Individual Investors, Puget Sound Chapter, 2010-present
Coordinator, Life Issues for Teens Program, Unitarian Universalist Church, 1995-1998   
Volunteer, KUSC Classical Radio 2000-2002


AFFILIATIONS


American Medical Writer's Association, 2010-present
Fellow of the American College of Obstetrics and Gynecology, 1993-present


PUBLICATIONS


Hilt R, Wolf C, Koprowicz K, Thomas E, Chandler M, Hao XL, Russell M, Le T, Hooks L, King B. Community child psychiatric medication experiences measured by an Internet-based, prospective parent survey of retail pharmacy customers. Community Ment Health J. 2014;50:172-8.

Saksena S, Sra J, Jordaens L, Kusumoto F, Knight B, Natale A, Kocheril A, Nanda NC, Nagarakanti R, Simon AM, Viggiano MA, Lockhandwala T, Chandler ML.  A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study.  Circ Arrhythm Electrophysiol. 2010; 3:571-7.

Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJGM and the RACE and AFFIRM Investigators.  Does intensity of rate-control influence outcome in atrial fibrillation?  An analysis of pooled data from the RACE and AFFIRM studies.  Europace. 2006;8:935-942.

Kellen JC, Schron EB, Milne J, Chandler ML, Berg CM, Ritchie DA, Paterson D, Sweeney PA, Nelson JD, Mickel M, AFFIRM Investigators and Coordinators.  Perceived effects on patients' health of participation in the atrial fibrillation follow-up ionvestigation of rhythm management study.  J Cardiovasc Nurs. 2006;21(5):388-96.

Bush, D, Martin LW, Leman R, Chandler M, Haywood LJ and the NHLBI AFFIRM Investigators.  Atrial fibrillation among African Americans, Hispanics and Caucasians:  clinical features and outcomes from the AFFIRM Trial.  J Natl Med Assoc. 2006;98:303-9.

O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Fillippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG, and the AFFIRM Investigators.  Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States.  Am J Cardiol. 2005;96:815-21.

Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA.  Insulin resistance and preeclampsia in gestational diabetes mellitus.  Diabetes Care. 2005;28:1995-2000.

Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL.  Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke?  Results from the AFFIRM study.  J Am Coll Cardiol. 2005;45:2026-33.

Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL and the AFFIRM Investigators.  Risk of proarrhythmic events in the AFFIRM study:  a multivariate analysis.  J Am Coll Cardiol. 2004;44:1276-1282.

Cooper HA, Bloomfield DA, Bush DS, Katcher MS, Rawlins M, Sacco JD, Chandler M and the AFFIRM Investigators.  Relation between achieved heart rate and outcome in patients with atrial fibrillation.  Am J Cardiol. 2004;93:1247-53.

Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O'Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL.  Analysis of cause-specific mortality in the atrial fibrillation follow-up investigation of rhythm management study.  Circulation. 2004;109:1973-80.

Oliveira J, Bailey C, Jones-Oliveira J, Dixon D, Gull D, Chandler M.  A computational model for the identification of biochemical pathways in the Krebs cycle.  J Comput Biol. 2003;10(1): 57-82.

Bird L, Young R, Chandler M, Anderson N. The effects of aminophylline and nifedipine on contractility of isolated pregnant human myometrium.  Am J Obstet Gynecol. 1987;157:171-79.